Tanacan, A. Et Al. 2019. Impact of extractable nuclear antigen, anti-double stranded DNA, antiphospholipid antibody, and anticardiolipin antibody positivity on obstetrical complications and pregnancy outcomes. Human Antibodies , vol.27, no.2 , 135-141.

Tanacan, A., Beksac, M. S., Orgul, G., Duru, S., ŞENER, B., & Karaagaoglu, E., (2019). Impact of extractable nuclear antigen, anti-double stranded DNA, antiphospholipid antibody, and anticardiolipin antibody positivity on obstetrical complications and pregnancy outcomes. Human Antibodies , vol.27, no.2, 135-141.

Tanacan, Atakan Et Al. "Impact of extractable nuclear antigen, anti-double stranded DNA, antiphospholipid antibody, and anticardiolipin antibody positivity on obstetrical complications and pregnancy outcomes," Human Antibodies , vol.27, no.2, 135-141, 2019

Tanacan, Atakan Et Al. "Impact of extractable nuclear antigen, anti-double stranded DNA, antiphospholipid antibody, and anticardiolipin antibody positivity on obstetrical complications and pregnancy outcomes." Human Antibodies , vol.27, no.2, pp.135-141, 2019

Tanacan, A. Et Al. (2019) . "Impact of extractable nuclear antigen, anti-double stranded DNA, antiphospholipid antibody, and anticardiolipin antibody positivity on obstetrical complications and pregnancy outcomes." Human Antibodies , vol.27, no.2, pp.135-141.

@article{article, author={Atakan Tanacan Et Al. }, title={Impact of extractable nuclear antigen, anti-double stranded DNA, antiphospholipid antibody, and anticardiolipin antibody positivity on obstetrical complications and pregnancy outcomes}, journal={Human Antibodies}, year=2019, pages={135-141} }